While this is likely to be more of an issue for peripheral T‐cell lymphomas due to the higher frequency of such mutations [16], variants in TET2, DNMT3A and TP53 are also recurrent in DLBCL. The gene discussed is TET2; the disease is diffuse large B-cell lymphoma.